Executive order threatens R & D when we need it most to fight COVID-19

In case you missed it, President Trump recently signed executive orders that would implement sweeping changes to the biopharmaceutical industry. While his intention may have been to help Americans afford their medicines, he instead declared war on medical innovation. Our nation ’s priority should be beating COVID-19 and getting America back on its feet economically, but these executive orders do the opposite.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development International Reference Pricing Coronavirus Source Type: news